SCD has
also been implicated in cancer cell proliferation and survival,
which could provide a potential link between
metabolic disorders and cancer development [36]. SCD
was found to be overexpressed in tumours from several
cancer types, including prostate [37], liver [38], kidney
[39] and breast cancer, where it correlates with reduced
survival